Compare Agilent Technologies Inc (A) vs iShares 0 3 Month Treasury Bond ETF (SGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs iShares 0 3 Month Treasury Bond ETF — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while iShares 0 3 Month Treasury Bond ETF trades at $100.59. The key difference: Agilent Technologies Inc pays a 0.69% dividend while iShares 0 3 Month Treasury Bond ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, iShares 0 3 Month Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| A | SGOV | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Fixed Income |
52-Week High | $157.20 | $100.74 |
52-Week Low | $110.24 | $100.28 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
SGOV, the iShares 0-3 Month Treasury Bond ETF, trades at $100.48, showing minimal daily movement. The technical outlook is bearish based on moving averages, while oscillators are neutral. Recent news highlights institutional stake adjustments and investor interest in ultra-short Treasury ETFs as a defensive pivot amid market volatility, with articles noting its role as a conservative cash alternative offering a yield around 3.8% (Seeking Alpha, 2026-08-03).
The ETF provides exposure to short-term U.S. Treasury bills, benefiting from rising interest rates but facing risks from Federal Reserve policy uncertainty and inflation data. Its principal protection and monthly distributions appeal to risk-averse investors, though price appreciation is limited by its nature. Key risks include interest rate changes and macroeconomic shifts influencing Treasury yields.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About iShares 0 3 Month Treasury Bond ETF
SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →
